149. Biochem Biophys Res Commun. 2018 May 23;499(4):973-978. doi:10.1016/j.bbrc.2018.04.030. Epub 2018 Apr 9.Protein ISGylation and free ISG15 levels are increased by interferon gamma inbreast cancer cells.Tecalco-Cruz AC(1), Cruz-Ramos E(2).Author information: (1)Programa de Investigación de Cáncer de Mama, Instituto de InvestigacionesBiomédicas, Universidad Nacional Autónoma de México, Ciudad de México, 04510,Mexico. Electronic address: atecalco@iibiomedicas.unam.mx.(2)Programa de Investigación de Cáncer de Mama, Instituto de InvestigacionesBiomédicas, Universidad Nacional Autónoma de México, Ciudad de México, 04510,Mexico.The induction of ISG15 by interferon (IFN)-α/β and subsequent protein ISGylation has been demonstrated in several cell types. However, regulation of free ISG15levels and ISGylation by other IFNs and its implications in some carcinomas have not yet been completely evaluated. Here, we demonstrated that free ISG15 andISGylation levels are enhanced by IFN-γ treatment in the estrogenreceptor-α-positive and -negative breast cancer cells, MCF-7 and MDA-MB-231,respectively. Specifically, IFN-γ increases free ISG15 levels in the cytoplasmand ISGylation in the nucleus and cytoplasm, but in a manner distinct betweenMCF-7 and MDA-MB-231 cells. Therefore, free ISG15 and ISGylation may play centralroles in mammary tumors by differentially modulating certain tumorigeniccharacteristics of estrogen receptor-α-positive and -negative breast cancercells.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.bbrc.2018.04.030 PMID: 29626479 